IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions
Draft as of 2025-09-10 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="cancer-histology-subgroup-athena-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet cancer-histology-subgroup-athena-vs</b></p><a name="cancer-histology-subgroup-athena-vs"> </a><a name="hccancer-histology-subgroup-athena-vs"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <code>http://fhir.ohdsi.org/CodeSystem/concepts</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>4078953</td><td>Squamous cell carcinoma, keratinizing</td></tr><tr><td>4166826</td><td>Squamous cell carcinoma, large cell, nonkeratinizing</td></tr><tr><td>4206785</td><td>Schneiderian carcinoma</td></tr><tr><td>4009590</td><td>Squamous cell carcinoma, spindle cell</td></tr><tr><td>4247661</td><td>Lymphoepithelial carcinoma</td></tr><tr><td>4029973</td><td>Basaloid squamous cell carcinoma</td></tr><tr><td>37156145</td><td>Squamous cell carcinoma</td></tr><tr><td>4312219</td><td>Adenoid squamous cell carcinoma</td></tr><tr><td>4052146</td><td>Squamous cell carcinoma, microinvasive</td></tr><tr><td>4175678</td><td>Giant cell carcinoma</td></tr><tr><td>4233949</td><td>Verrucous carcinoma</td></tr><tr><td>4191609</td><td>Papillary squamous cell carcinoma</td></tr><tr><td>37204531</td><td>Human papillomavirus positive squamous cell carcinoma</td></tr><tr><td>37204532</td><td>Human papillomavirus negative squamous cell carcinoma</td></tr><tr><td>4097305</td><td>Adenocarcinoma, intestinal type</td></tr><tr><td>37152526</td><td>Adenocarcinoma</td></tr><tr><td>4050978</td><td>Cystoadenocarcinoma</td></tr><tr><td>4247921</td><td>Mucinous adenocarcinoma</td></tr><tr><td>4238334</td><td>Ceruminous adenocarcinoma</td></tr><tr><td>4172953</td><td>Papillary adenocarcinoma</td></tr><tr><td>4022895</td><td>Adenoid cystic carcinoma</td></tr><tr><td>4253608</td><td>Mucoepidermoid carcinoma</td></tr><tr><td>4030121</td><td>Polymorphous low grade adenocarcinoma</td></tr><tr><td>4164740</td><td>Acinar cell carcinoma</td></tr><tr><td>4148292</td><td>Clear cell adenocarcinoma</td></tr><tr><td>4146684</td><td>Basal cell adenocarcinoma</td></tr><tr><td>4221403</td><td>Infiltrating duct carcinoma</td></tr><tr><td>4224593</td><td>Juvenile carcinoma of the breast</td></tr><tr><td>4323699</td><td>Paget's disease, extramammary (except Paget's disease of bone)</td></tr><tr><td>4321002</td><td>Epithelial-myoepithelial carcinoma</td></tr><tr><td>4066512</td><td>Carcinoma ex pleomorphic adenoma</td></tr><tr><td>4182993</td><td>Sebaceous adenocarcinoma</td></tr><tr><td>4271564</td><td>Carcinosarcoma</td></tr><tr><td>4212379</td><td>Oxyphilic adenocarcinoma</td></tr><tr><td>36714029</td><td>Small cell neuroendocrine carcinoma (SmCC)</td></tr><tr><td>37018672</td><td>Malignant poorly differentiated neuroendocrine carcinoma</td></tr><tr><td>4029971</td><td>Large cell neuroendocrine carcinoma (LCNEC)</td></tr><tr><td>4133828</td><td>Neuroendocrine tumor grade 1</td></tr><tr><td>4133297</td><td>Neuroendocrine tumor grade 2</td></tr><tr><td>1242310</td><td>Neuroendocrine carcinoma</td></tr><tr><td>4098585</td><td>Odontogenic tumor, malignant</td></tr><tr><td>37116966</td><td>Clear cell odontogenic carcinoma</td></tr><tr><td>4005818</td><td>Malignant odontogenic ghost cell tumor</td></tr><tr><td>44783808</td><td>Undifferentiated carcinoma of nasal sinus</td></tr><tr><td>4243327</td><td>Carcinoma, undifferentiated</td></tr><tr><td>4241843</td><td>Adenosquamous carcinoma</td></tr><tr><td>4284401</td><td>Teratocarcinoma</td></tr><tr><td>37116896</td><td>Nuclear protein in testis associated carcinoma</td></tr><tr><td>4295574</td><td>Olfactory neuroblastoma</td></tr><tr><td>4021372</td><td>Atypical lipomatous tumor</td></tr><tr><td>4102790</td><td>Liposarcoma, well differentiated</td></tr><tr><td>4284833</td><td>Dedifferentiated liposarcoma</td></tr><tr><td>4101123</td><td>Myxoid liposarcoma</td></tr><tr><td>4010104</td><td>Pleomorphic liposarcoma</td></tr><tr><td>1243142</td><td>Myxoid pleomorphic liposarcoma</td></tr><tr><td>4264204</td><td>Aggressive fibromatosis</td></tr><tr><td>4295283</td><td>Dermatofibrosarcoma protuberans</td></tr><tr><td>4207381</td><td>Epithelioid haemangioendothelioma</td></tr><tr><td>3661612</td><td>Angiosarcoma</td></tr><tr><td>4029021</td><td>Undifferentiated sarcoma</td></tr><tr><td>4239519</td><td>Myoepithelioma</td></tr><tr><td>4029680</td><td>Myoepithelial carcinoma</td></tr><tr><td>4028565</td><td>Ossifying fibromyxoid tumour</td></tr><tr><td>4195947</td><td>Mesenchymoma</td></tr><tr><td>45766484</td><td>Phosphaturic mesenchymal tumor, benign</td></tr><tr><td>45766485</td><td>Phosphaturic mesenchymal tumour, malignant</td></tr><tr><td>4239956</td><td>Angiomyxoma</td></tr><tr><td>4029526</td><td>Angiomatoid fibrous histiocytoma</td></tr><tr><td>45766528</td><td>Ewing sarcoma / peripheral neuroectodermal tumor</td></tr><tr><td>37311513</td><td>Biphenotypic sinonasal sarcoma</td></tr><tr><td>4135215</td><td>Adenosarcoma</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html"><code>http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100012">2000100012</a></td><td>Non-keratinizing squamous cell carcinoma: SMARCB1 (INI-1)-deficient Sinonasal Carcinoma</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100013">2000100013</a></td><td>Non-keratinizing squamous cell carcinoma: Transitional (cylindrical cell, Schneiderian) carcinoma</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100014">2000100014</a></td><td>Spindle cell (sarcomatoid) squamous cell carcinoma: SMARCB1 (INI-1)</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100015">2000100015</a></td><td>SMARCB1 (INI-1)-deficient Sinonasal undifferentiated Carcinoma</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100016">2000100016</a></td><td>Sinonasal SMARCA4 deficient carcinoma</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100017">2000100017</a></td><td>IDH2-mutated sinonasal undifferentiated neoplasm</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100018">2000100018</a></td><td>HPV-related Multiphenotypic Sinonasal Carcinoma</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100019">2000100019</a></td><td>NTRK-rearranged spindle cell neoplasm (emerging)</td></tr></table></li></ul></div>
</text>
<url
value="http://hl7.eu/fhir/ig/idea4rc/ValueSet/cancer-histology-subgroup-athena-vs"/>
<version value="0.1.0"/>
<name value="CancerHistologySubgroupVS"/>
<title value="Cancer histology subgroup: Athena"/>
<status value="draft"/>
<date value="2025-09-10T15:18:34+00:00"/>
<publisher value="IDEA4RC Project"/>
<contact>
<name value="IDEA4RC Project"/>
<telecom>
<system value="url"/>
<value value="https://www.idea4rc.eu/"/>
</telecom>
</contact>
<contact>
<name value="IDEA4RC Project"/>
<telecom>
<system value="url"/>
<value value="https://www.idea4rc.eu/"/>
</telecom>
</contact>
<description
value="Codes identifing the histology subgroup of the cancer."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="150"/>
<display value="Europe"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://fhir.ohdsi.org/CodeSystem/concepts"/>
<concept>
<code value="4078953"/>
<display value="Squamous cell carcinoma, keratinizing"/>
</concept>
<concept>
<code value="4166826"/>
<display
value="Squamous cell carcinoma, large cell, nonkeratinizing"/>
</concept>
<concept>
<code value="4206785"/>
<display value="Schneiderian carcinoma"/>
</concept>
<concept>
<code value="4009590"/>
<display value="Squamous cell carcinoma, spindle cell"/>
</concept>
<concept>
<code value="4247661"/>
<display value="Lymphoepithelial carcinoma"/>
</concept>
<concept>
<code value="4029973"/>
<display value="Basaloid squamous cell carcinoma"/>
</concept>
<concept>
<code value="37156145"/>
<display value="Squamous cell carcinoma"/>
</concept>
<concept>
<code value="4312219"/>
<display value="Adenoid squamous cell carcinoma"/>
</concept>
<concept>
<code value="4052146"/>
<display value="Squamous cell carcinoma, microinvasive"/>
</concept>
<concept>
<code value="4175678"/>
<display value="Giant cell carcinoma"/>
</concept>
<concept>
<code value="4233949"/>
<display value="Verrucous carcinoma"/>
</concept>
<concept>
<code value="4191609"/>
<display value="Papillary squamous cell carcinoma"/>
</concept>
<concept>
<code value="37204531"/>
<display
value="Human papillomavirus positive squamous cell carcinoma"/>
</concept>
<concept>
<code value="37204532"/>
<display
value="Human papillomavirus negative squamous cell carcinoma"/>
</concept>
<concept>
<code value="4097305"/>
<display value="Adenocarcinoma, intestinal type"/>
</concept>
<concept>
<code value="37152526"/>
<display value="Adenocarcinoma"/>
</concept>
<concept>
<code value="4050978"/>
<display value="Cystoadenocarcinoma"/>
</concept>
<concept>
<code value="4247921"/>
<display value="Mucinous adenocarcinoma"/>
</concept>
<concept>
<code value="4238334"/>
<display value="Ceruminous adenocarcinoma"/>
</concept>
<concept>
<code value="4172953"/>
<display value="Papillary adenocarcinoma"/>
</concept>
<concept>
<code value="4022895"/>
<display value="Adenoid cystic carcinoma"/>
</concept>
<concept>
<code value="4253608"/>
<display value="Mucoepidermoid carcinoma"/>
</concept>
<concept>
<code value="4030121"/>
<display value="Polymorphous low grade adenocarcinoma"/>
</concept>
<concept>
<code value="4164740"/>
<display value="Acinar cell carcinoma"/>
</concept>
<concept>
<code value="4148292"/>
<display value="Clear cell adenocarcinoma"/>
</concept>
<concept>
<code value="4146684"/>
<display value="Basal cell adenocarcinoma"/>
</concept>
<concept>
<code value="4221403"/>
<display value="Infiltrating duct carcinoma"/>
</concept>
<concept>
<code value="4224593"/>
<display value="Juvenile carcinoma of the breast"/>
</concept>
<concept>
<code value="4323699"/>
<display
value="Paget's disease, extramammary (except Paget's disease of bone)"/>
</concept>
<concept>
<code value="4321002"/>
<display value="Epithelial-myoepithelial carcinoma"/>
</concept>
<concept>
<code value="4066512"/>
<display value="Carcinoma ex pleomorphic adenoma"/>
</concept>
<concept>
<code value="4182993"/>
<display value="Sebaceous adenocarcinoma"/>
</concept>
<concept>
<code value="4271564"/>
<display value="Carcinosarcoma"/>
</concept>
<concept>
<code value="4212379"/>
<display value="Oxyphilic adenocarcinoma"/>
</concept>
<concept>
<code value="36714029"/>
<display value="Small cell neuroendocrine carcinoma (SmCC)"/>
</concept>
<concept>
<code value="37018672"/>
<display
value="Malignant poorly differentiated neuroendocrine carcinoma"/>
</concept>
<concept>
<code value="4029971"/>
<display value="Large cell neuroendocrine carcinoma (LCNEC)"/>
</concept>
<concept>
<code value="4133828"/>
<display value="Neuroendocrine tumor grade 1"/>
</concept>
<concept>
<code value="4133297"/>
<display value="Neuroendocrine tumor grade 2"/>
</concept>
<concept>
<code value="1242310"/>
<display value="Neuroendocrine carcinoma"/>
</concept>
<concept>
<code value="4098585"/>
<display value="Odontogenic tumor, malignant"/>
</concept>
<concept>
<code value="37116966"/>
<display value="Clear cell odontogenic carcinoma"/>
</concept>
<concept>
<code value="4005818"/>
<display value="Malignant odontogenic ghost cell tumor"/>
</concept>
<concept>
<code value="44783808"/>
<display value="Undifferentiated carcinoma of nasal sinus"/>
</concept>
<concept>
<code value="4243327"/>
<display value="Carcinoma, undifferentiated"/>
</concept>
<concept>
<code value="4241843"/>
<display value="Adenosquamous carcinoma"/>
</concept>
<concept>
<code value="4284401"/>
<display value="Teratocarcinoma"/>
</concept>
<concept>
<code value="37116896"/>
<display value="Nuclear protein in testis associated carcinoma"/>
</concept>
<concept>
<code value="4295574"/>
<display value="Olfactory neuroblastoma"/>
</concept>
<concept>
<code value="4021372"/>
<display value="Atypical lipomatous tumor"/>
</concept>
<concept>
<code value="4102790"/>
<display value="Liposarcoma, well differentiated"/>
</concept>
<concept>
<code value="4284833"/>
<display value="Dedifferentiated liposarcoma"/>
</concept>
<concept>
<code value="4101123"/>
<display value="Myxoid liposarcoma"/>
</concept>
<concept>
<code value="4010104"/>
<display value="Pleomorphic liposarcoma"/>
</concept>
<concept>
<code value="1243142"/>
<display value="Myxoid pleomorphic liposarcoma"/>
</concept>
<concept>
<code value="4264204"/>
<display value="Aggressive fibromatosis"/>
</concept>
<concept>
<code value="4295283"/>
<display value="Dermatofibrosarcoma protuberans"/>
</concept>
<concept>
<code value="4207381"/>
<display value="Epithelioid haemangioendothelioma"/>
</concept>
<concept>
<code value="3661612"/>
<display value="Angiosarcoma"/>
</concept>
<concept>
<code value="4029021"/>
<display value="Undifferentiated sarcoma"/>
</concept>
<concept>
<code value="4239519"/>
<display value="Myoepithelioma"/>
</concept>
<concept>
<code value="4029680"/>
<display value="Myoepithelial carcinoma"/>
</concept>
<concept>
<code value="4028565"/>
<display value="Ossifying fibromyxoid tumour"/>
</concept>
<concept>
<code value="4195947"/>
<display value="Mesenchymoma"/>
</concept>
<concept>
<code value="45766484"/>
<display value="Phosphaturic mesenchymal tumor, benign"/>
</concept>
<concept>
<code value="45766485"/>
<display value="Phosphaturic mesenchymal tumour, malignant"/>
</concept>
<concept>
<code value="4239956"/>
<display value="Angiomyxoma"/>
</concept>
<concept>
<code value="4029526"/>
<display value="Angiomatoid fibrous histiocytoma"/>
</concept>
<concept>
<code value="45766528"/>
<display value="Ewing sarcoma / peripheral neuroectodermal tumor"/>
</concept>
<concept>
<code value="37311513"/>
<display value="Biphenotypic sinonasal sarcoma"/>
</concept>
<concept>
<code value="4135215"/>
<display value="Adenosarcoma"/>
</concept>
</include>
<include>
<system
value="http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc"/>
<concept>
<code value="2000100012"/>
<display
value="Non-keratinizing squamous cell carcinoma: SMARCB1 (INI-1)-deficient Sinonasal Carcinoma"/>
</concept>
<concept>
<code value="2000100013"/>
<display
value="Non-keratinizing squamous cell carcinoma: Transitional (cylindrical cell, Schneiderian) carcinoma"/>
</concept>
<concept>
<code value="2000100014"/>
<display
value="Spindle cell (sarcomatoid) squamous cell carcinoma: SMARCB1 (INI-1)"/>
</concept>
<concept>
<code value="2000100015"/>
<display
value="SMARCB1 (INI-1)-deficient Sinonasal undifferentiated Carcinoma"/>
</concept>
<concept>
<code value="2000100016"/>
<display value="Sinonasal SMARCA4 deficient carcinoma"/>
</concept>
<concept>
<code value="2000100017"/>
<display value="IDH2-mutated sinonasal undifferentiated neoplasm"/>
</concept>
<concept>
<code value="2000100018"/>
<display value="HPV-related Multiphenotypic Sinonasal Carcinoma"/>
</concept>
<concept>
<code value="2000100019"/>
<display value="NTRK-rearranged spindle cell neoplasm (emerging)"/>
</concept>
</include>
</compose>
</ValueSet>